A
ELV icon

AustralianSuper’s Elevance Health ELV Stock Holding History

AustralianSuper’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9M Buy
51,406
+41,280
+408% +$15.3M 0.09% 148
2026
Q1 		$2.96M Sell
10,126
-2,150
-18% -$707K 0.02% 221
2025
Q4 		$4.3M Sell
12,276
-1,364
-10% -$461K 0.02% 202
2025
Q3 		$4.41M Buy
13,640
+1,384
+11% +$430K 0.02% 208
2025
Q2 		$4.77M Hold
12,256
– – 0.02% 203
2025
Q1 		$5.33M Buy
12,256
+1,947
+19% +$782K 0.03% 170
2024
Q4 		$3.8M Buy
10,309
+1,804
+21% +$755K 0.02% 173
2024
Q3 		$4.42M Buy
8,505
+607
+8% +$324K 0.02% 153
2024
Q2 		$4.28M Buy
7,898
+1,016
+15% +$537K 0.02% 151
2024
Q1 		$3.55M Hold
6,882
– – 0.02% 173
2023
Q4 		$3.25M Hold
6,882
– – 0.02% 191
2023
Q3 		$3M Hold
6,882
– – 0.02% 186
2023
Q2 		$3.06M Buy
+6,882
New +$3.17M 0.02% 190

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AustralianSuper's ELV Position: Q2 2026 in Review

AustralianSuper increased its Elevance Health (ELV) stake by 408% in Q2 2026, buying an estimated $15.3M and bringing the position to 51,406 shares worth $19.9M. The position accounts for 0.09% of the portfolio, ranked #148.

AustralianSuper first reported a position in ELV in Q2 2023 and has held it in 13 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • AustralianSuper held 51,406 shares of Elevance Health worth $19.9M as of Q2 2026.
  • AustralianSuper bought 41,280 Elevance Health shares in Q2 2026, an estimated $15.3M.
  • Elevance Health made up 0.09% of AustralianSuper's portfolio in Q2 2026, its #148 holding.
  • AustralianSuper first reported a position in Elevance Health in Q2 2023 and has held it in 13 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on AustralianSuper's 13F filing for Q2 2026, filed 12 Aug 2026.